TITLE: RT-qPCR for detection of SARS-CoV-2 in wastewater 
AUTHORS: David Findlay, Julie Bolland, Brindusa Cerghizan, Kirsty Campbell, David Thomson, Alexander Corbishley, David Gally, Stephen Fitzgerald, Alison Tidswell, Sean McAteer, Livia C T Scorza

[DESCRIPTION]
As part of the global response to the 2019 novel Coronavirus (SARS-CoV-2) pandemic, it was determined that SARS-CoV-2 RNA was detectable in the faeces of both symptomatic and asymptomatic patients (1). 

Further analysis demonstrated that a wastewater epidemiological (WWE) approach, similar to that used to track other viruses (i.e. Poliovirus), could be employed to monitor the spread of SARS-CoV-2. The presence of, or changes in concentration of viral RNA within the wastewater network can assist in monitoring the emergence of further viral peaks (2). Thus, monitoring the spread of Covid-19 using the WWE approach has been extensively explored in several countries (3). 

Viral RNA is extracted from a known volume of sewage treatment works influent and amplified by Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) 

RT-qPCR is a process whereby RNA is first converted to complementary DNA (cDNA) after which it can undergo amplification and quantification via PCR. The amplification of a non-target sequence, in this case the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), can also be carried out to act as an internal control.

This procedure, developed by Scottish Environment Protection Agency (SEPA) based on work in the Corbishley lab, Roslin Institute of the University of Edinburgh, outlines the method for amplification and quantification of the RNA extracted from crude sewage samples, but could equally apply to other RNA extracted from other types of environmental sample.

For viral RNA extraction from wastewater, please search for "RNA extraction from wastewater for detection of SARS-CoV-2" by the same authors of this protocol on protocols.io 

References:

1. Jones, D. L., Baluja, M. Q., Graham, D. W., Corbishley, A., McDonald, J. E., Malham, S. K., Hillary, L. S., Connor, T. R., Gaze , W. H., Moura , I. B., Wilcox, M. H., & Farkas , K. (2020).Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19.Science of the Total Environment.https://doi.org/10.1016/j.scitotenv.2020.1413644.

2. Fitzgerald, S., Rossi, G., Low, A., McAteer, S., O’Keefe, B., Findlay, D., Cameron, G. J., Pollard, P., Singleton, P. T. R., Ponton, G., Singer, A. C., Farkas, K., Jones, D., Graham, D. W., Quintela-Baluja, M., Tait-Burkard, C., Gally, D., Kao, R., & Corbishley, A.(2021).Site specific relationships between COVID-19 cases and SARS-CoV-2 viral load in wastewater treatment plant influent. Environmental Science and Technology. https://doi.org/10.1021/acs.est.1c05029

3. Wastewater SARS Public Health Environmental Response (W-SPHERE). https://sphere.waterpathogens.org/about



[BEFORE_START]
Samples should be processed as soon as possible after extraction. If previously frozen they must be analysed immediately after they are defrosted (on ice).

[GUIDELINES]
Performance and limitations

Ribonucleic Acid (RNA) is a highly labile biomolecule that very susceptible to degradation by ubiquitous enzymes known as RNases. Care must be taken to ensure that all reagents, equipment and working environment are free of RNase contamination.

False negative result may occur if insufficient target is present due to improper sample transport or storage conditions.

RNA is a highly labile biomolecule that must be protected from near-ubiquitous degrading RNase enzymes temperature fluctuations. All RNA work should be conducted “on ice” (RNase activity restricted at 4C) 

During the concentration process substances which can inhibit enzyme activity and therefore interfere with the qPCR process can also be extracted. Inhibition is monitored by the inclusion of an internal control added. The addition of extra protein (i.e. BSA) can help to reduce inhibition. 

If target sequences are present in very low starting concentrations then a clear signal to noise ratio will be difficult to achieve.

*In this protocol we used separated microbiological safety cabinets for mastermix preparation, positive template control and samples*
This protocol describes an RT-qPCR using AriaMx or MxPro qPCR instruments (Agilent). 

Interpretation guidelines

Once QC data has been checked raw data can be exported to XL and/or NEMS where the number of gene copy equivalent per litre can be calculated. As is standard for laboratory tests of this nature, there are two numerical values which are important to understanding how much weight should be given to the value.  These are known as the Limit of Detection (LoD) and the Limit of Quantification (LoQ). The limit of detection is the value at which the test has been determined to detect the virus material with certainty. The Limit of Quantification is the value, above which the test has been deemed to measure to virus material with a high degree of accuracy.

Values for reference:

Limit of Detection (LoD) = 1,316 gc/L
Limit of Quantification (LoQ) = 11,368 gc/L
Detected but not quantifiable or "Positive (DNQ)" description is given to the sample where the average value of the replicates is between the LoD and the LoQ (i.e. between 1,316 and 11,386 gene copies per litre).
"Weak Positive" will be given where two of three replicates return a positive signal but that signal is calculated as lower than the limit of detection (LoD). 
A sample is described as "Negative" where two replicates or two out of the three replicate tests return no response for the COVID markers.

Results are reported as follows:

If:

1. Replicate average > LoQ = Quantifiable positive result
 Report average value as gene copies per liter – ex. “12345 gc/L"

2. Replicate average >LoD but <LoQ = Detected but not quantifiable
Report as “Positive (DNQ)”

3. Replicate average <LoD = Weak Positive
Report as “Weak Positive” 

4. Two or more replicates produce No Cq (No Ct) result: Negative
Report as “Negative” 






[STEPS]
SECTION: Sample and equipment setup
1. At start of day, clean all surfaces with RNase away or 10% v/v bleach solution.

SECTION: Sample and equipment setup
2. Turn on UV lamps in the Master Mix preparation cabinet and Template addition cabinet for 20 minutes.

SECTION: Sample and equipment setup
3. Prior to analysis; ensure there are sufficient cooler blocks and/or ice baths for each workstation.
SECTION: Sample and equipment setup
4. Complete RT-qPCR Plate Worksheet and calculate the number of reactions (N) and volume of Master Mix required. See Appendix 1 for details. 
  

SECTION: Sample and equipment setup
5. Defrost sufficient RT-qPCR reagents and refrigerate until ready to use.
N.B. DO NOT REMOVE RT ENZYME FROM -20°C FREEZER UNTIL READY TO USE. MAINTAIN ON ICE AT ALL TIMES AND RETURN IMMEDIATELY AFTERWARDS.
SECTION: Sample and equipment setup
6. Defrost positive control and any required samples and maintain on ice.
SECTION: Standard curve preparation
7. For the standard curve preparation, use a 1:10 dilution series covering 5 dilution points (50000 to 5 copies of SARS-CoV2 ssRNA).


SECTION: Standard curve preparation
9. Transfer 25 µl from stock solution and add to labelled (5e+4) tube.
SECTION: Standard curve preparation
10. Mix and spin twice to ensure thorough homogenisation
SECTION: Standard curve preparation
11. Repeat step 9 and 10 until  dilution series is complete. Store on ice until needed.

SECTION: Master Mix Preparation
13. DEFROST AND MAINTAIN REAGENTS ON ICE 
 
     Reagent      Volume (µl)   per   reaction (N)       Per sample        RT-qPCR reaction   mix      10      35        RT enzyme      1      3.5        Primer/Probe mix      1.5      5.25        BSA      2      7        Nuclease-free   water      0.5      1.75        Template      5      17.5        Total volume      20       70   

The list containing primers and probes sequences and concentration can be found in the attached file below

  

SECTION: Master Mix Preparation
14. In the Master Mix cabinet, working on ice, combine the master mix reagents (excluding template). Invert x5 to mix.
SECTION: Master Mix Preparation
15. Dispense 15 µl master mix to each well required of a 96 well PCR plate (on ice).
SECTION: Master Mix Preparation
16. Add 5 µl of nuclease-free water to "no template control" (NTC) wells and cap.
SECTION: Master Mix Preparation
17. Cover plate and transfer to sample addition cabinet
SECTION: Plate setup
18. Add 5 µl of sample to appropriate wells and cap.
SECTION: Plate setup
19. Cover and transfer to Template addition cabinet.
SECTION: Plate setup
20. Add 5 µl of each positive control dilution series to appropriate wells and cap.
SECTION: Plate setup
21. Spin plate down (1000 RCF for 1 minute) and transfer the plate to the qPCR instrument. Lower and lock the upper tray in place and close the door
SECTION: RT-qPCR using AriaMx Real-Time PCR system
22. Select “New Experiment” and “Quantitative PCR (Fluorescence Probe)”.
SECTION: RT-qPCR using AriaMx Real-Time PCR system
23. In “Plate setup” select all wells and assign as per Plate Worksheet and choose relevant filters
N1 – FAM and ROX.
E gene (optional) – HEX and ROX
PRRS – Cy5 and ROX
SECTION: RT-qPCR using AriaMx Real-Time PCR system
24. In Thermal Profile tab set the following parameters:

 

SECTION: RT-qPCR using AriaMx Real-Time PCR system
25. Save file with desired name
SECTION: RT-qPCR using AriaMx Real-Time PCR system
26. Select "Run experiment"
SECTION: RT-qPCR using AriaMx Real-Time PCR system
27. After Run Save file and copy to PC for detailed plate setup.
SECTION: RT-qPCR using AriaMx Real-Time PCR system
28. Open file using Aria software
SECTION: RT-qPCR using AriaMx Real-Time PCR system
29. Highlight all wells and assign ROX as reference dye.
SECTION: RT-qPCR using AriaMx Real-Time PCR system
30. Highlight sample wells and assign sample identifier (this can be imported from qPCR worksheet XL).
SECTION: RT-qPCR using AriaMx Real-Time PCR system
31. Highlight “Standard” wells and assign appropriate concentration values
SECTION: Standard curve analytical quality control
32. Before results can be determined highlight all wells and select the following columns: Well, Well Name, Well Type, Ct (dRn) or Cq (∆Rn), Quantity (copies), RSq (dRn) or R² (∆Rn), Slope (dRn) and Efficiency (%). 
SECTION: Standard curve analytical quality control
33. Check the baseline threshold values (~0.03 FAM and ~0,1 Cy5).
SECTION: Standard curve analytical quality control
33.1. Ensure that NTC wells are negative (No Cq).
SECTION: Standard curve analytical quality control
33.2. Ensure that Standard Curve meets the following criteria:
R-Sq is >0.9, 
Slope (y) is between -3.1 and -3.92 and
Efficiency is between 80 and 110%. 

If any of these parameters are exceeded then analysis should be repeated.
SECTION: Interpretation of raw data
34. Once QC data has been checked raw data can be exported to XL where the number of gene copy equivalent per litre can be calculated.
SECTION: Interpretation of raw data
35. Results should be reported as follows:

1.Replicate mean >LoQ = Quantifiable Positive Result (ie 12345 gc/L)

2.Replicate mean >LoD but <LoQ = “Positive (DNQ)”

3.Replicate mean <LoD = “Weak Positive” 

4.If both replicates produce No Cq  result = “Negative” 

LoQ= limit of quantification
LoD= limit of detection

Check "Guidelines & Warnings" section for more details on the LoQ and LoD values

SECTION: Standard curve preparation
8. In positive template cabinet label 5 tubes and add 225 µl of RNase-free water to each and place on ice.
SECTION: Standard curve preparation
12. Go to "Standard curve analytical Control" steps for data interpretation (32 - 33)